Medications

US looks to reboot nonprescription drug system

The U.S. Food and Drug Administration is seeking to revamp its system for regulating hundreds of over-the-counter drugs, saying the decades-old process is not flexible enough to keep pace with modern medical developments.

Feb 21, 2014
popularity not rated yet | comments 0

Afatinib: Added benefit depends on mutation status

Afatinib (trade name: GIOTRIF) has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations ...

Feb 19, 2014
popularity not rated yet | comments 0